Clinical Trials
3 trialsNCT05547737 2022-09-21
NSCLC
Henan Cancer Hospital
Unknown
NCT05005468 2021-08-13
CAMFA-L
Shanghai Chest Hospital
Phase 2 Unknown
NCT04506242 2020-09-09
Camrelizumab With Apatinib as Neoadjuvant Therapy for Participants With Resectable Non-Small Cell Lung Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2 Unknown